Publicaciones en colaboración con investigadores/as de Hospital Morales Meseguer (12)

2024

  1. Correction to: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA (Scientific Reports, (2022), 12, 1, (13057), 10.1038/s41598-022-17271-3)

    Scientific Reports

  2. WHO/ICC Classification for Myelodysplastic Neoplasms/Syndromes Performs Better for Subtype Cytomorphological Diagnosis?

    Diagnostics, Vol. 14, Núm. 15

2022

  1. Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

    Scientific Reports, Vol. 12, Núm. 1

2019

  1. Increased systemic malondialdehyde levels and decreased Mo/Co, Co/Fe2+ ratios in patients with long-term dental titanium implants and amalgams

    Journal of Clinical Medicine, Vol. 8, Núm. 1

  2. Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline

    Journal of Oncology Pharmacy Practice, Vol. 25, Núm. 2, pp. 484-486

2017

  1. Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL

    European Journal of Haematology, Vol. 98, Núm. 2, pp. 142-148

2013

  1. Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: A triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease

    Cardiovascular Drugs and Therapy, Vol. 27, Núm. 1, pp. 37-48

  2. One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease

    Pharmacological Research, Vol. 72, pp. 69-82

  3. Resveratrol in primary and secondary prevention of cardiovascular disease: A dietary and clinical perspective

    Annals of the New York Academy of Sciences, Vol. 1290, Núm. 1, pp. 37-51

2012

  1. Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple-blind, 6-month follow-up, placebo-controlled, randomized trial

    Molecular Nutrition and Food Research, Vol. 56, Núm. 5, pp. 810-821

  2. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease

    American Journal of Cardiology, Vol. 110, Núm. 3, pp. 356-363

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229